Anticancer Drugs Olaparib Oncology Pharmacology Physiotherapy

Olaparib (Drug Interaction-6)

In this article, we will discuss Olaparib (Drug Interaction-6). So, let’s get started.

Drugs That May Decrease Olaparib Plasma Concentrations
In patients (n=22), co-administration of rifampicin, a strong CYP3A inducer, decreased AUC of olaparib by 87%. A moderate CYP3A inducer, efavirenz, is predicted to decrease the AUC of olaparib by
approximately 60%.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.